Zentalis Pharmaceuticals Llc Stock Technical Analysis
| ZNTL Stock | USD 2.12 0.11 4.93% |
As of the 26th of February, Zentalis Pharmaceuticals maintains the Mean Deviation of 4.84, market risk adjusted performance of (0.11), and Standard Deviation of 7.19. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zentalis Pharmaceuticals Llc, as well as the relationship between them. Please check out Zentalis Pharmaceuticals risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if Zentalis Pharmaceuticals is priced fairly, providing market reflects its latest price of 2.12 per share. Please also validate Zentalis Pharmaceuticals jensen alpha, which is currently at (0.32) to confirm the company can sustain itself at a future point.
Zentalis Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Zentalis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ZentalisZentalis |
Zentalis Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 9.5 | Buy | 11 | Odds |
Most Zentalis analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Zentalis stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Zentalis Pharmaceuticals, talking to its executives and customers, or listening to Zentalis conference calls.
Zentalis Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Zentalis Pharmaceuticals Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Zentalis Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Zentalis Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Zentalis Pharmaceuticals Llc. You can use it to identify possible trend reversals for Zentalis Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Zentalis Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Zentalis Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Zentalis Pharmaceuticals Llc applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that Zentalis Pharmaceuticals Llc market price will keep on failing further. It has 122 observation points and a regression sum of squares at 30.71, which is the sum of squared deviations for the predicted Zentalis Pharmaceuticals price change compared to its average price change.About Zentalis Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Zentalis Pharmaceuticals Llc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Zentalis Pharmaceuticals Llc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Zentalis Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Zentalis Pharmaceuticals. By analyzing Zentalis Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Zentalis Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Zentalis Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2024 | 2025 (projected) | Days Sales Outstanding | 21.5K | 19.1K | PTB Ratio | 2.61 | 2.48 |
Zentalis Pharmaceuticals February 26, 2025 Technical Indicators
Most technical analysis of Zentalis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Zentalis from various momentum indicators to cycle indicators. When you analyze Zentalis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 4.84 | |||
| Coefficient Of Variation | (2,397) | |||
| Standard Deviation | 7.19 | |||
| Variance | 51.65 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 42.4 | |||
| Value At Risk | (11.11) | |||
| Potential Upside | 8.36 | |||
| Skewness | 0.8161 | |||
| Kurtosis | 5.61 |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zentalis Pharmaceuticals Llc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis Pharmaceuticals. If investors know Zentalis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zentalis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zentalis Pharmaceuticals is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zentalis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zentalis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zentalis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.